Florida Gulf Coast University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Florida Gulf Coast University sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 1 currently recruiting 8 completed early-phase tilt top decile by trial count

Florida Gulf Coast University: 11 sponsored US clinical trials, 1 recruiting.

Florida Gulf Coast University sponsors 11 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 8 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Asymptomatic Condition, with 1 trials.

Top-decile sponsor footprint

Florida Gulf Coast University ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

11 total, page 1 of 1

RECRUITING Early Phase 1

Promoting Playfulness

NCT06625255
TERMINATED NA

The Effects of a Specific Exercise Program on Subjects With Cervicogenic Headache

NCT05500378
COMPLETED NA

Brainwave Activity Response on Common Physical Therapy Intervention

NCT04542707
COMPLETED NA

Instrument Assisted Soft Tissue Mobilization Effect on Blood Flow

NCT04785079
COMPLETED NA

Comparison of the Effect of Spine Grade I and II Manipulation and a PNE Video on Brainwaves: Pilot Study

NCT04908670
COMPLETED NA

A Peer-mediated Vocational Social Skills Program for Young Adults With Autism

NCT04468620
COMPLETED NA

The Effect of a Talocrural Thrust Manipulation on Lateral Ankle Ligament Integrity in a Subgroup of Healthy Individuals

NCT03731767
TERMINATED NA

Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches

NCT03730896
COMPLETED NA

Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System

NCT03728751
COMPLETED

Activity Levels and Rehabilitation Outcomes of Patients Post-stroke

NCT03257111
COMPLETED NA

Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture

NCT02579343

Phase Distribution

PhaseTrial count
Phase 1 1

Therapeutic Areas

Asymptomatic Condition 1
Developmental Delay (Disorder) 1
Healthy 1

What is open in the Florida Gulf Coast University pipeline

1 recruiting of 11 indexed (9% open); 8 completed (73%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Asymptomatic Condition (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Florida Gulf Coast University: open-pipeline peers nationwide

Peers matched on 11 registered trials and 9% open enrollment, not the therapeutic-area sidebar.

Florida Gulf Coast University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080 0%2%4%6%8%10% Total trials Recruiting share Florida Gulf Coast UniversityAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeAlkermesDBV TechnologiesGenfitHiberCell
Florida Gulf Coast University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Florida Gulf Coast University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 9% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Florida Gulf Coast University page

11 registered trials is a research-attention snapshot, not an endorsement of Florida Gulf Coast University or any single study.

  • 1 of Florida Gulf Coast University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Asymptomatic Condition is the condition Florida Gulf Coast University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Asymptomatic Condition trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Florida Gulf Coast University pipeline card: 11 registered trials from official public datasets.Report a data error.